The company has completed its strategic expansion of its product portfolio, officially adding commonly used injectable APIs such as indocyanine green for injection, lidocaine hydrochloride, and gentamicin sulfate. Simultaneously, it has completed the necessary OEM manufacturing registration documents for pharmaceutical formulations. Leveraging its mature capabilities in customs declaration, commodity inspection, and clearance, the company can provide overseas clients with a one-stop service encompassing raw material supply, pharmaceutical formulation manufacturing, and registration assistance, catering to the mass production needs of hospitals and pharmaceutical companies in multiple countries.